Benzinga Rankings give you vital metrics on any stock – anytime.
Explore Kiniksa Pharmaceuticals stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for KNSA.
You can purchase shares of Kiniksa Pharmaceuticals (NASDAQ:KNSA) through any online brokerage.
Other companies in Kiniksa Pharmaceuticals’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), ARS Pharmaceuticals (NASDAQ:SPRY), 89bio (NASDAQ:ETNB), Syndax Pharmaceuticals (NASDAQ:SNDX) and Ascentage Pharma Group (NASDAQ:AAPG).
Kiniksa Pharmaceuticals has a consensus price target of $36.43.
The stock price for Kiniksa Pharmaceuticals (NASDAQ: KNSA) is $18.1737 last updated March 14, 2025 at 7:51 PM EDT.
There are no upcoming dividends for Kiniksa Pharmaceuticals.
Kiniksa Pharmaceuticals’s Q1 earnings are confirmed for Tuesday, April 22, 2025.
There is no upcoming split for Kiniksa Pharmaceuticals.
Kiniksa Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.